1
|
Asha B, Goudanavar P, Koteswara Rao G, Gandla K, Raghavendra Naveen N, Majeed S, Muthukumarasamy R. QbD driven targeted pulmonary delivery of dexamethasone-loaded chitosan microspheres: Biodistribution and pharmacokinetic study. Saudi Pharm J 2023; 31:101711. [PMID: 37564747 PMCID: PMC10410579 DOI: 10.1016/j.jsps.2023.101711] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2023] [Accepted: 07/20/2023] [Indexed: 08/12/2023] Open
Abstract
Inhaling drugs, on the other hand, is limited mainly by the natural mechanisms of the respiratory system, which push drug particles out of the lungs or make them inefficient once they are there. Because of this, many ways have been found to work around the problems with drug transport through the lungs. Researchers have made polymeric microparticles (MP) and nanoparticles as a possible way to get drugs into the lungs. They showed that the drug could be trapped in large amounts and retained in the lungs for a long time, with as little contact as possible with the bloodstream. MP were formulated in this study to get dexamethasone (DMC) into the pulmonary area. The Box-Behnken design optimized microspheres preparation to meet the pulmonary delivery prerequisites. Optimized formulation was figured out based on the desirability approach. The mass median aerodynamic diameter (MMAD) of the optimized formula (O-DMC-MP) was 8.46 ± 1.45 µm, and the fine particle fraction (FPF) was 77.69 ± 1.26%. This showed that it made suitable drug delivery system, which could make it possible for MP to settle deeply in the lung space after being breathed in. With the first burst of drug release, it was seen that drug release could last up to 16 h. Also, there was no clear sign that the optimized formulation was toxic to the alveoli basal epithelial cells in the lungs, as supported by cytotoxic studies in HUVEC, A549, and H1299 cell lines. Most importantly, loading DMC inside MP cuts the amount of drug into the bloodstream compared to plain DMC, as evident from biodistribution studies. Stability tests have shown that the product can stay the same over time at both the storage conditions. Using chitosan DMC-MP can be a better therapeutic formulation to treat acute respiratory distress syndrome (ARDS).
Collapse
Affiliation(s)
- B.R. Asha
- Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G. Nagar, Karnataka 571448, India
| | - Prakash Goudanavar
- Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G. Nagar, Karnataka 571448, India
| | - G.S.N. Koteswara Rao
- Department of Pharmaceutics, Shobhaben Pratapbhai Patel School of Pharmacy & Technology Management, SVKM’s NMIMS, Vile Parle (W), Mumbai 400056, Maharashtra, India
| | - Kumaraswamy Gandla
- Department of Pharmaceutical Analysis, Chaitanya (Deemed to be University), Hanamkonda 506001, Telangana, India
| | - N. Raghavendra Naveen
- Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G. Nagar, Karnataka 571448, India
| | - Shahnaz Majeed
- Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal college of Medicine Perak, No 3, Jalan Green town, Ipoh 30450, Perak, Malaysia
| | - Ravindran Muthukumarasamy
- Faculty of Pharmacy and Health Sciences, Universiti Kuala Lumpur Royal college of Medicine Perak, No 3, Jalan Green town, Ipoh 30450, Perak, Malaysia
| |
Collapse
|
2
|
Raghavendra Naveen N, Anitha P, Gowthami B, Goudanavar P, Fattepur S. QbD assisted formulation design and optimization of thiol pectin based Polyethyleneglycol and Montmorillonite(PEG/MMT) nanocomposite films of neomycin sulphate for wound healing. J Drug Deliv Sci Technol 2023. [DOI: 10.1016/j.jddst.2023.104348] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/16/2023]
|
3
|
Basavarajappa GM, Priyanka KM, Goudanavar P, Narasimha LG, Naveen NR, Gowthami B, Fattepur S, Shiroorkar PN, Nagaraja S, Telsang M, Jasthi VC, Sreenivasalu PKP. A spotlight on application of microwave-assisted modifications of plant derived polymers in designing novel drug delivery systems. Des Monomers Polym 2023; 26:106-116. [PMID: 37008384 PMCID: PMC10064828 DOI: 10.1080/15685551.2023.2194176] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 04/04/2023] Open
Abstract
Polymers are a fundamental part of numerous industries and can be conjugated with many other materials and components to have a vast array of products. Biomaterials have been extensively studied for their application in pharmaceutical formulation development, tissue engineering, and biomedical areas. However, the native form of many polymers has limitations concerning microbial contamination, susceptibility, solubility, and stability. Chemical or physical modifications can overcome these limitations by tailoring the properties of polymers to meet several requirements. The polymer modifications are interdisciplinary, cutting across conventional materials, physics, biology, chemistry, medicine, and engineering limitations. Microwave irradiation has become a well-established technique for a few decades to drive and promote chemical modification reactions. This technique allows ease of temperature and power control to perform the synthesis protocols efficiently. Additionally, microwave irradiation contributes to green and sustainable chemistry. In this contribution, microwave-assisted polymer modifications were described with a special focus on their application in developing several novel dosage forms.
Collapse
Affiliation(s)
| | - K M Priyanka
- Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G.Nagar, Karnataka, India
| | - Prakash Goudanavar
- Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G.Nagar, Karnataka, India
| | | | - N. Raghavendra Naveen
- Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G.Nagar, Karnataka, India
- CONTACT N. Raghavendra Naveen Department of Pharmaceutics, Sri Adichunchanagiri College of Pharmacy, Adichunchanagiri University, B.G.NagarKarnataka, 571448, India
| | - Buduru Gowthami
- Annamacharya College of Pharmacy, New Boyanapalli, Rajampet, Andhra Pradesh, India
| | - Santosh Fattepur
- School of Pharmacy, Management and Science University, Shah Alam, Selangor, Malaysia
- Santosh Fattepur School of Pharmacy, School of Pharmacy, Seksyen 13, Shah Alam40100, Malaysia
| | | | - Sreeharsha Nagaraja
- Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Hofuf, Al-Ahsa, Kingdom of Saudi Arabia
- Department of Pharmaceutics, Vidya Siri College of Pharmacy, Off Sarjapura Road, Bangalore, India
- Sreeharsha Nagaraja Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Hofuf, Al-Ahsa31982, Kingdom of Saudi Arabia
| | - Mallikarjun Telsang
- Department of Surgery, College of Medicine, King Faisal University, Al-Ahsa, Saudi Arabia
| | - Veeriah Chowdary Jasthi
- Department of Oral and Maxillofacial Surgery and Diagnostic Sciences, College of Dentistry, King Faisal University, Al-Ahsa, Saudi Arabia
| | | |
Collapse
|
4
|
Murtale SA, Goudanavar P, Acharya A, Lokapur J. Formulation Development of Sustain Release Tablets of Lornoxicam using Chemically Modified Xanthan Gum. Int J Pharm Investig 2022. [DOI: 10.5530/ijpi.2022.2.34] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022] Open
|
5
|
Nair A, Naveen NR, Fattepur S, Goudanavar P, Koppuravuri N, Gowthami B, Telsang M, Osmani R, Sreeharsha N, Habeebuddin M. Exploring cross-linked tragacanth as novel excipient-proof-of-concept. Pharmacogn Mag 2022. [DOI: 10.4103/pm.pm_601_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
6
|
Goudanavar P, Ramesh B, Fattepur S, Sreeharsha N. Irinotecan Engineered Proniosomes: In vitro and In vivo Characterization. JPRI 2021. [DOI: 10.9734/jpri/2021/v33i41a32322] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Objective: The focus of this research has been to improve efficacy, decrease tolerance and increase the irinotecan pharmacokinetic profile.
Methods: Proniosomesformulated with various surfactants, cholesterol and dicetyl phosphate using the slurry method. A slurry process was used to prepare proniosomes with maltodextrin as the carrier by using surfactants span 20, span 60, tween 20 and tween 80.
Results: The preparations were characterized in terms of shape and specific surface area, entrapment efficacy, in vitro release studies, in vivo tissue diffusion and stability testing. The proniosome surface was found to be smoother in nature showing thin and compact layer with skim milk powder. For formulation 2 (73.94±2.8%), the maximum entrapment efficacy was found.
Conclusion: The formulation 3 obtained the desired maximum release profile within 24 hours (98.06%). The in vivo tissue distribution studies for the proniosomes reveal that the drug was preferentially targeted to liver followed by the alveolus and lymphatic system.Stability studies have indicated that the most acceptable condition for storage of the formulation 2 was 4o C. Proniosomes provide an acceptable method to the carrier for targeted therapy. These can be held at specific sites and can release the drug for a prolonged period of time.
Collapse
|